Chronic cicatrizing conjunctivitis

Current Opinion in Ophthalmology

Volumn 12, Issue 4, 2001, Pages 250-257

  Faraj, Hani G ^a   Hoang Xuan, Thanh ^a,b  

^a BICHAT HOSPITAL   (France)

^b FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; DAPSONE; DOXYCYCLINE; ERYTHROMYCIN; HUMAN IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MINOCYCLINE; MUCOLYTIC AGENT; OXYTETRACYCLINE; SALAZOSULFAPYRIDINE; SODIUM CHLORIDE; STEROID; SULFAPYRIDINE; TETRACYCLINE;

ANTIBIOTIC THERAPY; AUTOIMMUNE DISEASE; CHRONIC INFLAMMATION; CONJUNCTIVITIS; DIAGNOSTIC PROCEDURE; DRUG INDUCED DISEASE; FIBROSIS; HUMAN; HYGIENE; KERATOCONJUNCTIVITIS; MUCOUS MEMBRANE PEMPHIGOID; PRIORITY JOURNAL; PROGNOSIS; REVIEW; ROSACEA; SCAR FORMATION; SYMPTOMATOLOGY;

ANIMALS; AUTOIMMUNE DISEASES; CHRONIC DISEASE; CONJUNCTIVA; CONJUNCTIVITIS; CONJUNCTIVITIS, ALLERGIC; FIBROSIS; HUMANS; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; ROSACEA;

EID: 0034890645     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-200108000-00003     Document Type: Review

References (93)

1. Basic mechanisms in pathology
2. Acute and chronic inflammation
3. Tissue repair: Cellular, growth, fibrosis, and wound healing
4. Autoimmune phenomena in ocular cicatricial pemphigoid
5. Serum levels of tumor necrosis factor-alpha and interleukin 6 in ocular cicatricial pemphigoid
6. The T-cell receptor in normal and inflamed human conjunctiva
7. Antibasement antibody-mediated experimental conjunctivitis
8. Antibodies against conjunctival basement membrane zone
9. Immunosuppressive therapy in ocular cicatricial pemphigoid
10. Cicatricial pemphigoid
11. Antiepiligrin cicatricial pemphigoid
12. The role of antibody to human beta4 integrin in conjunctival basement membrane separation: Possible in vitro model for ocular cicatricial pemphigoid
13. Identification of ocular cicatricial pemphigoid antibody binding site(s) in human beta4 integrin
14. Identification of a basement membrane zone antigen reactive with circulating IgA antibody in ocular cicatricial pemphigoid
15. The major cicatricial pemphigoid antigen is a 180-kD protein that shows immunologic cross-reactivities with the bullous pemphigoid antigen
16. Association of DQW7(DQB1*0301) with ocular cicatricial pemphigoid
17. Association of HLA-DR4 with ocular cicatricial pemphigoid
18. Immunopathology of cicatricial pemphigoid affecting the conjunctiva
19. Immunophenotypic analysis of the inflammatory infiltrate in ocular cicatricial pemphigoid
20. Hyperproliferation of conjunctival fibroblasts in patients with cicatricial pemphigoid
21. Eosinophil granule proteins expressed in ocular cicatricial pemphigoid
22. The conjunctiva in acute and chronic mucous membrane pemphigoid: An immunohistochemical analysis
23. Mast cells in conjunctiva affected by cicatricial pemphigoid
24. Conjunctival fibrosis in ocular cicatricial pemphigoid- the role of cytokines
25. Relation of cholesterol-stimulated Staphylococcus aureus growth to chronic blepharitis
26. The role of wax and sterol esters of meibomian secretions in chronic blepharitis
27. Lid flora in blepharitis
28. Tear fluid gelatinase B activity correlates with IL-1 concentration and fluorescein clearance in ocular rosacea
29. Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant
30. Bacterial lipases and chronic blepharitis
31. Ocular rosacea: A histologic and immunopathologic study
32. Atopic keratoconjunctivitis
33. Immunopathology of atopic keratoconjunctivitis
34. Mast cell hyperplasia in atopic keratoconjunctivitis, an immunohistochemical study
35. Tear levels of interferon-gamma, interleukin (IL)-2, IL4 and IL5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis
36. Conjunctival deposition of eosinophil major basic protein, neutrophil elastase, and mast cell tryptase in atopic keratoconjunctivitis
37. Ocular cicatricial pemphigoid
38. Ocular cicatricial pemphigoid in a twelve-year-old boy
39. Cicatrizing conjunctivitis
40. Glaucoma in patients with ocular cicatricial pemphigoid
41. Improved detection of disease progression in ocular cicatricial pemphigoid
42. Progression of disease in ocular cicatricial pemphigoid
43. Immunofluorescent studies in ocular cicatricial pemphigoid
44. The value of biopsies in the evaluation of chronic progressive conjunctival cicatrisation
45. Increasing the diagnostic yield of conjunctival biopsy in patients with suspected ocular cicatricial pemphigoid
46. Immunohistopathologic testing in patients suspected of ocular cicatricial pemphigoid
47. Comparaison de l'immunofluorescence directe et de l'immunomicroscopie électronique directe dans les conjonctivites autoimmunes
48. Immunoelectron microscopic study on the conjunctiva in cicatricial pemphigoid
49. Management of acquired bullous skin diseases
50. Systemic chemotherapy for ocular cicatricial pemphigoid
51. Sulphapyridine: A new agent for the treatment of ocular cicatricial pemphigoid
52. Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: A preliminary study
53. Remission and recurrence after withdrawal of therapy for ocular cicatricial pemphigoid
54. Long term results of systemic chemotherapy for ocular cicatricial pemphigoid
55. Ocular cicatricial pemphigoid. Retrospective analysis of risk factors and complications
56. Results of buccal mucosal grafting for patients with medically controlled ocular cicatricial pemphigoid
57. Inferior retractor plication surgery for lower lid entropion with trichiasis in ocular cicatricial pemphigoid
58. Long-term results of mucous membrane grafting in ocular cicatricial pemphigoid. Implications for patient selection and surgical considerations
59. Keratoprosthesis in pemphigoid and Stevens-Johnson syndrome
60. Penetrating keratoplasty in cicatrizing conjunctival diseases
61. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome
62. Living related conjunctival limbal allograft for the treatment of stem cell deficiency
63. Management and outcome of cataract surgery in ocular cicatricial pemphigoid
64. Acne rosacea with keratitis in childhood
65. Ocular rosacea in blacks
66. An epidemiological study of rosacea
67. Meibomian gland disease. Classification and grading of lid changes
68. Association of ocular rosacea and keratoconjunctivitis sicca
69. Ocular rosacea
70. Ocular rosacea
71. The efficacy of topical metronidazole in the treatment of ocular rosacea
72. Oxytetracycline in the treatment of ocular rosacea: A double-blind trial
73. Efficacy of doxycycline and tetracycline in ocular rosacea
74. The effect of minocycline in severe ocular rosacea
75. Ocular aspects of rosacea
76. Ocular complications of atopic dermatitis and other eczemas
77. Atopic keratoconjunctivitis
78. Long term follow-up of patients with atopic keratoconjunctivitis
79. Clinical features of atopic keratoconjunctivitis
80. Role of Staphylococcus aureus in chronic allergic conjunctivitis
81. Ocular atopy and mycotic keratitis
82. Eczema and keratoconus
83. Association of eosinophil granule major protein with atopic cataract
84. Retinal detachment with atopic dermatitis similar to traumatic retinal detachment
85. Conjunctivitis of allergic origin: Immunologic mechanisms and current approaches to therapy
86. The immunomodulatory effect of topical cyclosporin in atopic keratoconjunctivitis
87. Cyclosporin in atopic dermatitis: A multicenter placebo-controlled study
88. Systemic cyclosporine A in severe atopic keratoconjunctivitis
89. Plasmapheresis treatment in patients with severe atopic keratoconjunctivitis
90. Penetrating keratoplasty in atopic keratoconjunctivitis
91. Sclerokeratitis following keratoplasty in atopy
92. Fibrosing conjunctivitis